Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state
The DOI matches its Crossref record.
Abstract
Streptococcal preparation OK-432 is a bacterial immunopotentiator extensively used in Japan for adjuvant cancer therapy. Using a C57BL/6 mouse model, OK-432 was found to induce multiple cytokines including the Th1 polarizing cytokine IL-12. Expression of IL-12 protein by murine splenocytes was restricted to macrophages and B cells and led to high levels of IFN-γ production from both CD4+ and CD8+ T cells. Of the Th2 cytokines IL-4 and IL-10, only IL-10 protein was detected and originated primarily from the adherent cell population. Its expression was delayed relative to IL-12. A similar pattern of cytokine induction was observed from human PBMCs. OK-432-driven IFN-γ production was inhibited by anti-IL-12 Ab, anti-IL-2 Ab, anti-TNF-α Ab, and anti-IL-2R α Ab, suggesting that IFN-γ production from Th1 cells is induced by the cooperation action of these cytokines through the IL-2R α pathway. When compared with another widely used immunopotentiator bacillus Calmette-Guérin (BCG), OK-432 was a stronger IL-12 and IFN-γ inducer. Furthermore, the mechanism of IFN-γ induction by OK-432 differed from BCG in that coincident granulocyte-macrophage CSF and IL-1 expression played little to no role. These results suggest that OK-432 is a potent multicytokine inducer, specifically a strong inducer of IL-12, and that OK-432 may exert its antitumor effect by promoting a Th1-dominant state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.617 · Cited by 468
Miettinen, M., Matikainen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M., & Julkunen, I. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.6058-6062.1998 · Cited by 343
TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings
Shetab Boushehri, M. A., & Lamprecht, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00691 · Cited by 161
Miwa, S., Nishida, H., Tanzawa, Y., Takeuchi, A., Hayashi, K., Yamamoto, N., Mizukoshi, E., Nakamoto, Y., Kaneko, S., & Tsuchiya, H. (2017) · Cancer · doi:10.1002/cncr.30606 · Cited by 95
“been reported to be immunomodulatory and to have potential therapeutic properties for cancer immunotherapy.(35,36) Nakamoto et al(15) reported that OK-432”
BackgroundMortensen, R., Nissen, T. N., Blauenfeldt, T., Christensen, J. P., Andersen, P., & Dietrich, J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500804 · Cited by 55
Metadata
- Authors
- Fujimoto, T., Duda, R. B., Szilvasi, A., Chen, X., Mai, M., & O'Donnell, M. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-06
- Volume
- 158
- Issue
- 12
- Pages
- 5619-5626
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1583569488
- Cited by
- 118
- References
- 0
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.